Mercer University College of Pharmacy faculty member Martin D’Souza, Ph.D., recently began research into designing a microparticle vaccine for COVID-19.

Dr. D’Souza has previously used patented nanotechnology to design and deliver nanovaccines for infectious diseases and cancer. His approach involves using tiny “bead-like” nanoparticles and microparticles to deliver drugs and vaccines.

“The advantage of putting a vaccine in a microparticle is that it looks even more foreign to the body,” said Dr. D’Souza. “Therefore, the body creates an even stronger immune response.”

Continue reading about D’Souza’s work on a COVID-19 vaccine at news.mercer.edu.

 

Do you have a story idea or viewpoint you'd like to share with The Den?
Get in touch with us by emailing den@mercer.edu or submitting this online form.
Kyle Sears
Kyle is the director of media relations at Mercer. In addition to being the primary media contact for most academic and administrative units of the university, he coordinates hometown and university news releases and serves as editor of the News@Mercer e-newsletter and Reach magazine.​